MedTrace Logo

Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors

NCT01572766 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2012-04-06

No results posted yet for this study

Summary

The study seeks to determine the impact of assessing risk for osteoporosis in women on patient and physician behaviors through a pharmacist directed osteoporosis screening program. Women will be offered a heel ultrasound to screen for their bone density and may or may not be asked questions about their risk for bone fracture. Pharmacists will counsel and educate all women on ways to prevent the onset of osteoporosis. Women will be telephoned three months after the screening and asked a series of 10 questions to follow up on decisions made by their physicians or changes made to their health behaviors related to bone health.

Conditions

Interventions

OTHER

FRAX Assessment Tool

FRAX Assessment Tool is designed to assess risk for fracture based on country of origin, race, and other factors.

Sponsors & Collaborators

  • Warner Chilcott

    collaborator INDUSTRY

  • Duquesne University

    lead OTHER

Principal Investigators

  • Hildegarde J Berdine, PharmD · Duquesne University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-11-30
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572766 on ClinicalTrials.gov